Prenetics

About:

Prenetics is a genetic and diagnostic health testing company that helps to identify health risks with the use of DNA sequencing technology.

Website: https://www.prenetics.com

Twitter/X: Prenetics

Top Investors: 500 Global, Xen Capital, Ping An, Apis Partners, Beyond Ventures

Description:

Prenetics is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the top sports distribution companies in the USA. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by ‘enhancing life through science’.

Total Funding Amount:

$188M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Hong Kong, Hong Kong Island, Hong Kong

Founded Date:

2014-01-01

Contact Email:

care(AT)prenetics.com

Founders:

Danny Yeung, Lawrence Tzang, Michael M. Yang

Number of Employees:

251-500

Last Funding Date:

2022-05-18

IPO Status:

Public

Industries:

© 2025 bioDAO.ai